Whether or not transaminase-lowering drugs and lipid-lowering drugs can be taken together cannot be determined directly, but needs to be judged based on the specific drug chosen. Usually the two drugs can be taken together to improve health.
Transaminase-lowering drugs usually include glycyrrhizic acid drugs and hepatoprotective and enzyme-lowering drugs, such as diammonium glycyrrhizinate and polyene phosphatidylcholine. Transaminase-lowering drugs can effectively protect liver tissues and functions, as well as protect liver cell membranes, which can effectively reduce the amount of transaminases in the blood, thus promoting liver health.
Lipid-lowering drugs usually include statins and fibrates, such as atorvastatin, rivastigmine and fenofibrate. After taking the drugs can effectively reduce blood lipids and stabilize vascular plaque, thus promoting the effect of cardiovascular health. Whether lipid-lowering drugs and transaminase-lowering drugs can be taken at the same time needs to be judged according to the specific drugs taken. Lipid-lowering drugs, especially tatin drugs, may cause transaminase elevation, mild elevation can be combined with hepatoprotective enzyme-lowering drugs, severe liver injury, need to stop the drug, at the same time the application of hepatoprotective drugs, the specific use of drugs, should be carried out under the guidance of a doctor.
When taking lipid-lowering drugs and aminotransferase-lowering drugs, one should consult the doctor’s advice to choose the appropriate method of use.